← Every company
Intra-Cellular Therapies Inc Patents
What Intra-Cellular Therapies Inc has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
ITCI on carbonthat →Filings on file
61
Granted
1
Still pending
60
Filed under
2 names
61 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| ORGANIC COMPOUNDSA61K 31/4985, A61K 9/0019, A61K 45/06, C07B 59/002, C07B2200/05, C07D 471/04, C07D 471/16, A61K2300/00Filed as INTRA-CELLULAR THERAPIES, INC.2026-06-16Peng LI | pending |
| NOVEL METHODSA61K 31/445, A61K 31/4985, C07D 471/14, A61P 25/14, A61P 25/20, A61P 25/28, A61P 31/00, A61P 43/00, A61P 25/22, A61P 3/04, A61P 21/02, A61P 25/18, A61P 25/24, A61P 25/00, A61P 25/16, A61P 25/06, A61K 31/5383, A61K 45/06, C07D 471/16, A61K2300/00Filed as INTRA-CELLULAR THERAPIES, INC.2026-05-01Sharon MATES | pending |
| METHODS FOR TREATING MAJOR DEPRESSIVE DISORDER COMPRISING ADMINISTERING LUMATEPERONEA61K 31/4985, A61P 25/22, A61P 25/24, A61K 9/00, A61K 9/4858, A61K 9/4866, A61K 31/137, A61K 31/55, A61K 45/06Filed as INTRA-CELLULAR THERAPIES, INC.2026-04-01Robert E. DAVIS | pending |
| ORGANIC COMPOUNDSFiled as INTRA-CELLULAR THERAPIES, INC.2026-03-27PENG LI | pending |
| NOVEL METHODSFiled as INTRA-CELLULAR THERAPIES, INC.2026-01-09Robert E DAVIS | pending |
| PHARMACEUTICAL COMPOSITIONS AND METHODSFiled as INTRA-CELLULAR THERAPIES, INC.2025-11-20SHARON MATES | pending |
| METHODS OF TREATING DEPRESSION AND ANXIETYA61K 31/4985, A61P 25/24, A61K 9/006, A61K 31/13, A61K 31/135, A61K 31/137, A61K 31/138, A61K 31/155, A61K 31/165, A61K 31/197, A61K 31/343, A61K 31/36, A61K 31/38, A61K 31/381, A61K 31/42, A61K 31/485, A61K 31/496, A61K 31/55, A61K 31/551, A61K 31/5513, A61K 31/554, A61K 38/07, A61K 45/06, C07D 471/16, A61K2300/00Filed as INTRA-CELLULAR THERAPIES, INC.2025-11-14Gretchen SNYDER | pending |
| NOVEL METHODSFiled as INTRA-CELLULAR THERAPIES, INC.2025-11-05Robert E DAVIS | pending |
| METHODS OF TREATING CENTERAL NERVOUS SYSTEM DISORDERS COMPRISING ADMINISTERING DEUTERATED LUMATEPERONE AND A NITRIC OXIDE DONORA61K 31/4985, C07D 471/16, A61P 25/08, A61K 45/06Filed as INTRA-CELLULAR THERAPIES, INC.2025-10-23Robert E. DAVIS | pending |
| NOVEL METHODSFiled as INTRA-CELLULAR THERAPIES, INC.2025-10-08Robert E DAVIS | pending |
| NOVEL METHODSFiled as INTRA-CELLULAR THERAPIES, INC.2025-10-03Robert E DAVIS | pending |
| ORGANIC COMPOUNDA61K 45/06, C07D 519/00, A61P 25/28, A61P 25/18, A61P 25/00, A61K 31/4985Filed as INTRA-CELLULAR THERAPIES, INC.2025-09-02Peng LI | pending |
| NOVEL METHODSA61K 9/2013, A61K 31/4985, A61P 25/00, A61K 9/2009, A61K 9/2054, A61K 9/284, A61K 45/06, C07B2200/13Filed as INTRA-CELLULAR THERAPIES, INC.2025-09-02Peng LI | pending |
| NOVEL METHODSA61K 9/4858, A61K 31/4985, A61P 25/28, A61P 25/22, A61P 25/18, A61P 25/24, A61P 25/00, A61K 9/0053, A61K 9/16, A61K 9/4825, A61K 9/485, A61K 9/4866, A61K 9/4891Filed as INTRA-CELLULAR THERAPIES, INC.2025-09-02Peng LI | pending |
| NOVEL METHODSA61P 25/22, A61K 31/4985, Y02A 50/30, A61P 25/18, A61P 25/24, A61P 29/00Filed as INTRA-CELLULAR THERAPIES, INC.2025-08-19Sophie DUTHEIL | pending |
| LUMATEPERONE AND DERIVATIVES THEREOF FOR MODULATING THE NERVOUS SYSTEMA61K 31/4985, A61P 25/00Filed as INTRA-CELLULAR THERAPIES, INC.2025-08-18Robert E. DAVIS | pending |
| NOVEL METHODSA61K 9/0019, A61K 31/437, A61K 31/5383, A61P 25/20, A61P 25/28, A61P 43/00, A61P 25/22, A61P 25/18, A61P 25/24, A61P 25/00, A61K 9/0024, A61K 9/1647, A61K 9/5153, A61K 31/4985, A61K 45/06, A61K 47/34, A61K2300/00Filed as INTRA-CELLULAR THERAPIES, INC.2025-08-08Kimberly VANOVER | pending |
| AMORPHOUS SOLID DISPERSIONSA61K 31/4985, A61P 25/28, A61P 25/22, A61P 3/04, A61P 25/18, A61P 25/24, A61P 25/06, A61K 9/0019, A61K 9/0024, A61K 9/0053, A61K 9/10, A61K 9/1617, A61K 9/1635, A61K 9/1641, A61K 9/1652, A61K 9/2013, A61K 9/2027, A61K 9/2031, A61K 9/2054, A61K 9/4858, A61K 9/4866, A61K 47/38, C07D 471/16Filed as INTRA-CELLULAR THERAPIES, INC.2025-08-06Peng Li | pending |
| ORGANIC COMPOUNDSA61K 31/519, C07K 16/2818, A61P 35/00, A61K 39/39533, A61K2300/00Filed as INTRA-CELLULAR THERAPIES, INC.2025-07-16Gretchen SNYDER | pending |
| ORGANIC COMPOUNDSFiled as INTRA-CELLULAR THERAPIES, INC.2025-07-03PENG LI | pending |
| ORGANIC COMPOUNDSFiled as INTRA-CELLULAR THERAPIES, INC.2025-07-03PENG LI | pending |
| ORGANIC COMPOUNDSFiled as INTRA-CELLULAR THERAPIES, INC.2025-07-03PENG LI | pending |
| ORGANIC COMPOUNDSC07D 471/16, A61K 31/4745, A61K 31/4747, A61K 31/4985, A61K 31/499, A61K 31/542, A61K 31/55, A61K 31/553, A61K 31/554, C07D 471/20, C07D 498/16, C07D 513/16Filed as INTRA-CELLULAR THERAPIES, INC.2025-06-27Peng LI | pending |
| ORGANIC COMPOUNDSA61K 31/4985, C07D 471/16, A61P 25/20, A61P 25/28, A61P 25/30, A61P 25/22, A61P 3/04, A61P 25/04, A61P 25/18, A61P 25/24, A61P 1/00, A61P 15/00, A61P 25/16, A61P 29/00, A61P 25/06, A61K 9/0019, A61K 45/06, C07B 59/002, C07B2200/05, A61K2300/00Filed as INTRA-CELLULAR THERAPIES, INC.2025-06-17Peng LI | pending |
| METHODS OF TREATING NEUROPATHIC PAINA61K 31/4985, A61P 25/02, C07D 471/16Filed as INTRA-CELLULAR THERAPIES, INC.2025-06-16Robert DAVIS | pending |
| METHODSFiled as INTRA-CELLULAR THERAPIES, INC.2025-06-13Robert E. DAVIS | pending |
| NOVEL USESA61K 31/519, A61P 31/14, A61K 31/4015, A61K 45/06, A61K2300/00Filed as INTRA-CELLULAR THERAPIES, INC.2025-06-06Peng LI | pending |
| ORGANIC COMPOUNDSFiled as INTRA-CELLULAR THERAPIES, INC.2025-06-02PENG LI | pending |
| TRANSMUCOSAL METHODS FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONSA61K 31/4985, A61P 1/14, A61P 25/20, A61P 25/28, A61P 25/22, A61P 3/04, A61P 25/04, A61P 25/18, A61P 25/24, A61P 15/08, A61P 25/00, A61P 25/16, A61P 25/06, A61K 9/0021, A61K 9/0034, A61K 9/0036, A61K 9/0043, A61K 9/006, A61K 9/06, A61K 47/32, A61K 47/36, A61K 47/38, A61K 47/42Filed as INTRA-CELLULAR THERAPIES, INC.2025-05-16Peng LI | pending |
| NOVEL METHODSFiled as INTRA-CELLULAR THERAPIES, INC.2025-05-16Robert E DAVIS | pending |
| NOVEL COMPOSITIONS, DEVICES AND METHODSFiled as INTRA-CELLULAR THERAPIES, INC.2025-05-15PENG LI | pending |
| NOVEL COMPOSITIONS, DEVICES, AND METHODSA61K 9/0019, A61K 9/10, A61K 31/4985, A61K 47/22, A61K 47/34Filed as INTRA-CELLULAR THERAPIES, INC.2025-05-15Peng LI | pending |
| NOVEL COMPOSITIONS, DEVICES AND METHODSFiled as INTRA-CELLULAR THERAPIES, INC.2025-05-15PENG LI | pending |
| ORGANIC COMPOUNDSA61K 45/06, C07D 471/14, A61P 25/36, A61P 25/20, A61P 25/22, A61P 25/04, A61P 25/00, A61K 31/485, A61K 31/4985Filed as INTRA-CELLULAR THERAPIES, INC.2025-05-12Peng LI | pending |
| SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESISA61P 25/00, C07C 309/30, C07D 471/16, A61K 31/4985, C07D 471/04Filed as INTRA-CELLULAR THERAPIES, INC.2025-04-11Peng LI | pending |
| ORGANIC COMPOUNDSFiled as INTRA-CELLULAR THERAPIES, INC.2025-04-02PENG LI | pending |
| NOVEL METHODSFiled as INTRA-CELLULAR THERAPIES, INC.2025-04-01Robert E DAVIS | pending |
| ORGANIC COMPOUNDSFiled as INTRA-CELLULAR THERAPIES, INC.2025-03-27Peng LI | pending |
| AMORPHOUS SOLID DISPERSIONSA61K 31/4985, A61P 25/28, A61P 25/22, A61P 3/04, A61P 25/18, A61P 25/24, A61P 25/06, A61K 9/0019, A61K 9/0024, A61K 9/0053, A61K 9/10, A61K 9/1617, A61K 9/1635, A61K 9/1641, A61K 9/1652, A61K 9/2013, A61K 9/2027, A61K 9/2031, A61K 9/2054, A61K 9/4858, A61K 9/4866, A61K 47/38, C07D 471/16Filed as INTRA-CELLULAR THERAPIES, INC.2025-03-21Peng LI | pending |
| ORGANIC COMPOUNDSA61K 31/4985, C07D 471/16, A61P 25/14, A61P 25/20, A61P 25/28, A61P 43/00, A61P 25/22, A61P 3/04, A61P 25/04, A61P 29/02, A61P 21/02, A61P 25/18, A61P 25/24, A61P 1/00, A61P 25/00, A61P 25/16, A61K 45/06, C07B 59/002, C07D 471/14Filed as INTRA-CELLULAR THERAPIES, INC.2025-02-28Sharon MATES | pending |
| ORGANIC COMPOUNDSC07D 471/16, A61K 9/4825, A61K 9/4891, A61K 9/5031, A61K 31/4985, A61K 47/34, A61K 47/38, C07D 471/14Filed as INTRA-CELLULAR THERAPIES, INC.2025-02-26Peng LI | pending |
| NOVEL SALTS AND CRYSTALSA61K 31/4985, C07D 471/16, A61P 25/00, A61K 9/0019, A61K 9/10, A61K 47/10, A61K 47/38, C07D 487/16Filed as INTRA-CELLULAR THERAPIES, INC.2025-01-29Peng LI | pending |
| METHODS OF TREATING ACUTE DEPRESSION AND ANXIETYA61K 31/4985, A61P 25/24, A61K 9/006, A61K 31/13, A61K 31/135, A61K 31/137, A61K 31/138, A61K 31/155, A61K 31/165, A61K 31/197, A61K 31/343, A61K 31/36, A61K 31/38, A61K 31/381, A61K 31/42, A61K 31/485, A61K 31/496, A61K 31/55, A61K 31/551, A61K 31/5513, A61K 31/554, A61K 38/07, A61K 45/06, C07D 471/16, A61K2300/00Filed as INTRA-CELLULAR THERAPIES, INC.2024-12-30Gretchen SNYDER | 12496300 |
| METHODS AND COMPOSITIONS FOR SLEEP DISORDERS AND OTHER DISORDERSA61K 31/437, A61K 31/4985, A61P 25/14, A61P 25/20, A61P 43/00, A61P 25/18, A61P 25/24, A61P 5/06, A61P 25/00, A61P 25/16, A01N 43/42, A61K 9/0053, A61K 31/198, A61K 31/44, A61K 31/5383, A61K 45/06, C07D 471/14, C07D 498/14Filed as INTRA-CELLULAR THERAPIES, INC.2024-12-10Sharon MATES | pending |
| ORGANIC COMPOUNDA61P 25/18, C07D 471/16, A61P 25/22, A61P 25/24, A61P 25/00, A61K 9/0019, A61K 9/1647, A61K 31/4985, B32B 5/00, B82Y 5/00Filed as INTRA-CELLULAR THERAPIES, INC.2024-12-04Peng LI | pending |
| USESA61K 31/519, A61P 25/16Filed as INTRA-CELLULAR THERAPIES, INC.2024-12-03Robert E. DAVIS | pending |
| ORGANIC COMPOUNDSA61K 31/4985, A61K 31/519, C07D 471/14, C07D 471/16, A61P 25/14, A61P 25/20, A61P 25/28, A61P 25/22, A61P 3/04, A61P 25/18, A61P 25/24, A61P 1/00, A61P 25/00, A61P 25/16, A61P 25/06, A61K 9/0004, A61K 31/5383, A61K 45/06, A61K2300/00Filed as INTRA-CELLULAR THERAPIES, INC.2024-11-26Wei YAO | pending |
| NOVEL METHODSFiled as INTRA-CELLULAR THERAPIES, INC.2024-11-22SOPHIE DUTHEIL | pending |
| PHARMACEUTICAL COMPOSITIONS AND METHODSFiled as INTRA-CELLULAR THERAPIES, INC.2024-11-20Sharon MATES | pending |
| PHARMACEUTICAL COMPOSITIONS AND METHODSFiled as INTRA-CELLULAR THERAPIES, INC.2024-11-20Sharon MATES | pending |
| PHARMACEUTICAL COMPOSITIONS AND METHODSFiled as INTRA-CELLULAR THERAPIES, INC.2024-11-20Sharon MATES | pending |
| NOVEL METHODSA61P 25/18, A61K 31/4985, A61P 25/22, Y02A 50/30, A61P 25/24, A61P 25/00, A61P 29/00Filed as INTRA-CELLULAR THERAPIES, INC.2024-11-18Sophie DUTHEIL | pending |
| ORGANIC COMPOUNDSFiled as INTRA-CELLULAR THERAPIES, INC2024-10-28PENG LI | pending |
| ORGANIC COMPOUNDSFiled as INTRA-CELLULAR THERAPIES, INC.2024-10-28PENG LI | pending |
| ORGANIC COMPOUNDSFiled as INTRA-CELLULAR THERAPIES, INC.2024-10-28PENG LI | pending |
| ORGANIC COMPOUNDSFiled as INTRA-CELLULAR THERAPIES, INC.2024-10-24Peng LI | pending |
| ORGANIC COMPOUNDSFiled as INTRA-CELLULAR THERAPIES, INC.2024-10-24Peng LI | pending |
| PROCESS FOR PREPARING INTERMEDIATES FOR 1-(4-FLUOROPHENYL)-4-((6bR,10aS)-3-METHYL-2,3,6b,9,10,10a-HEXAHYDRO-1H-PYRIDO[3’,4’:4,5]PYRROLO[1,2,3-de]QUINOXALIN-8(7H)-YL)BUTAN-1-ONEC07D 471/04, C07D 471/16, A61P 15/10, A61P 25/20, A61P 43/00, A61P 25/22, A61P 3/04, A61P 25/04, A61P 25/18, A61P 25/24, A61P 1/00, A61P 15/00, A61P 25/00, A61P 25/26, A61P 1/04, A61P 25/06, C07D 471/02, C07D 471/12, C07D 471/14Filed as INTRA-CELLULAR THERAPIES, INC.2024-10-03John Charles TOMESCH | pending |
| NOVEL COMPOSITIONS AND METHODSA61K 9/7061, A61K 31/4985, A61K 9/0014, A61K 9/006, A61K 9/7084, A61K 47/12, A61K 47/14, A61K 47/186, A61K2300/00Filed as INTRA-CELLULAR THERAPIES, INC.2024-09-23Peng LI | pending |
| ORGANIC COMPOUNDSC07D 471/14, C07D 487/14, A61P 25/00, A61K 31/4985, C07B2200/09Filed as INTRA-CELLULAR THERAPIES, INC.2024-09-13Peng LI | pending |
| ORGANIC COMPOUNDSC07D 471/14, C07D 471/16, A61P 25/00, A61K 31/437, A61K 31/4985, A61K 31/517, C07D 471/04Filed as INTRA-CELLULAR THERAPIES, INC.2024-09-13Peng LI | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.